Area of research
Materials Chemistry · Biomedical Engineering
Research interest
Research interests include Nanoplatforms for cancer theranostics, Advanced Nanomaterials in Catalysis, Luminescence and Fluorescent Materials, and Advanced biosensing and bioanalysis techniques.
Recent Progress in CO <sub>2</sub> Conversion: An Overview of Catalytic Strategies for Sustainable Fuel and Chemical Synthesis
The relationship of miR-155 host gene polymorphism in the susceptibility of cancer: a systematic review and meta-analysis
Additive manufacturing of Fe–Mn–Al–C lightweight steel by laser powder bed fusion: The role of laser scanning speed on forming quality, microstructure and properties
Microstructure and mechanical properties of Fe–30Mn–9Al–C–3Ni low-density steel manufactured by selective laser melting
Cucurbit[8]uril-based water-dispersible assemblies with enhanced optoacoustic performance for multispectral optoacoustic imaging
Characterization of polyhydroxybutyrate (PHB) synthesized by newly isolated rare actinomycetes Aquabacterium sp. A7-Y
Synthesis of hierarchically porous zirconium-based metal-organic framework@silica core-shell stationary phase through etching strategy for liquid chromatography
Directing the Architecture of Surface-Clean Cu<sub>2</sub>O for CO Electroreduction
NRF2 and FXR dual signaling pathways cooperatively regulate the effects of oleanolic acid on cholestatic liver injury
Circularly Polarized Organic Room Temperature Phosphorescence from Amorphous Copolymers
Facile preparation of antibacterial MOF‐fabric systems for functional protective wearables
ZIF-8 Nanoparticles for Facile Processing into Useful Fabric Composites
An Ultrasmall SnFe<sub>2</sub>O<sub>4</sub> Nanozyme with Endogenous Oxygen Generation and Glutathione Depletion for Synergistic Cancer Therapy
Linkage Engineering by Harnessing Supramolecular Interactions to Fabricate 2D Hydrazone-Linked Covalent Organic Framework Platforms toward Advanced Catalysis
The within-host viral kinetics of SARS-CoV-2
An ShRNA Based Genetic Screen Identified Sesn2 as a Potential Tumor Suppressor in Lung Cancer via Suppression of Akt-mTOR-p70S6K Signaling
Proteomic Profiling of Paclitaxel Treated Cells Identifies a Novel Mechanism of Drug Resistance Mediated by PDCD4